Corrigendum to "Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors" [Bioorgan. Med. Chem. Lett. 50 (2021) 128352]

Bioorg Med Chem Lett. 2022 Jul 1:67:128758. doi: 10.1016/j.bmcl.2022.128758. Epub 2022 Apr 25.

Authors

Yufang Xiao¹, Bayard R Huck², Ruoxi Lan³, Lizbeth DeSelm³, Xiaoling Chen³, Hui Qiu³, Constantin Neagu³, Theresa Johnson³, Igor Mochalkin³, Anna Gardberg³, Xuliang Jiang³, Hui Tian³, Vikram Dutt³, Dusica Santos³, Jared Head³, Jennifer Jackson³, Sakeena Syed³, Jing Lin³, Erik Wilker³, Jianguo Ma³, Anderson Clark³, Andreas Machl³, Donald Bankston³, Christopher C V Jones³, Andreas Goutopoulos³, Brian Sherer³

Affiliations

¹ EMD Serono Research and Development Institute, Inc., 45A Middlesex Turnpike, Billerica, MA 01821, USA. Electronic address: yufang.xiao@emdserono.com.
² EMD Serono Research and Development Institute, Inc., 45A Middlesex Turnpike, Billerica, MA 01821, USA. Electronic address: Bayard.Huck@emdserono.com.
³ EMD Serono Research and Development Institute, Inc., 45A Middlesex Turnpike, Billerica, MA 01821, USA.

PMID: 35484006
DOI: 10.1016/j.bmcl.2022.128758

No abstract available

Publication types

Published Erratum